logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Layade, Adedamola
    Born in November 1984
    Individual (9 offsprings)
    Officer
    2023-02-01 ~ now
    OF - Director → CIF 0
    Layade, Adedamola
    Individual (9 offsprings)
    Officer
    2023-02-01 ~ now
    OF - Secretary → CIF 0
    Mr Adedamola Layade
    Born in November 1984
    Individual (9 offsprings)
    Person with significant control
    2023-02-01 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of shares – 75% or more as a member of a firmCIF 0
    PE - Ownership of shares – 75% or more with control over the trustees of a trustCIF 0
    PE - Right to appoint or remove directors as a member of a firmCIF 0
    PE - Right to appoint or remove directors with control over the trustees of a trustCIF 0
    PE - Ownership of voting rights - 75% or more as a member of a firmCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or more with control over the trustees of a trustCIF 0
parent relation
Company in focus

LAYANSON PHARMA LTD

Period: 2023-02-01 ~ now
Company number: 14632770 16304758... (more)
Registered name
LAYANSON PHARMA LTD - now 16304758... (more)
Recent Standard Industrial Classification
86900 - Other Human Health Activities
46460 - Wholesale Of Pharmaceutical Goods
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Turnover/Revenue
1,269,898 GBP2024-03-01 ~ 2025-02-28
686,635 GBP2023-02-01 ~ 2024-02-29
Cost of Sales
-846,303 GBP2024-03-01 ~ 2025-02-28
-401,344 GBP2023-02-01 ~ 2024-02-29
Gross Profit/Loss
423,595 GBP2024-03-01 ~ 2025-02-28
285,291 GBP2023-02-01 ~ 2024-02-29
Administrative Expenses
-378,187 GBP2024-03-01 ~ 2025-02-28
-187,369 GBP2023-02-01 ~ 2024-02-29
Operating Profit/Loss
45,408 GBP2024-03-01 ~ 2025-02-28
97,922 GBP2023-02-01 ~ 2024-02-29
Other Interest Receivable/Similar Income (Finance Income)
149 GBP2024-03-01 ~ 2025-02-28
Interest Payable/Similar Charges (Finance Costs)
-45,015 GBP2024-03-01 ~ 2025-02-28
-273 GBP2023-02-01 ~ 2024-02-29
Profit/Loss on Ordinary Activities Before Tax
542 GBP2024-03-01 ~ 2025-02-28
97,649 GBP2023-02-01 ~ 2024-02-29
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-72,181 GBP2024-03-01 ~ 2025-02-28
-39,253 GBP2023-02-01 ~ 2024-02-29
Profit/Loss
-71,639 GBP2024-03-01 ~ 2025-02-28
58,396 GBP2023-02-01 ~ 2024-02-29
Intangible Assets
139,333 GBP2025-02-28
181,133 GBP2024-02-29
Property, Plant & Equipment
211,136 GBP2025-02-28
157,011 GBP2024-02-29
Fixed Assets
350,469 GBP2025-02-28
338,144 GBP2024-02-29
Total Inventories
53,000 GBP2025-02-28
30,000 GBP2024-02-29
Debtors
196,524 GBP2025-02-28
284,654 GBP2024-02-29
Cash at bank and in hand
90,159 GBP2025-02-28
23,318 GBP2024-02-29
Current Assets
339,683 GBP2025-02-28
337,972 GBP2024-02-29
Net Current Assets/Liabilities
29,711 GBP2025-02-28
41,114 GBP2024-02-29
Total Assets Less Current Liabilities
380,180 GBP2025-02-28
379,258 GBP2024-02-29
Net Assets/Liabilities
-21,542 GBP2025-02-28
58,397 GBP2024-02-29
Equity
Called up share capital
1 GBP2025-02-28
1 GBP2024-02-29
Retained earnings (accumulated losses)
-21,543 GBP2025-02-28
58,396 GBP2024-02-29
Equity
-21,542 GBP2025-02-28
58,397 GBP2024-02-29
Issue of Equity Instruments
Called up share capital
1 GBP2023-02-01 ~ 2024-02-29
Issue of Equity Instruments
1 GBP2023-02-01 ~ 2024-02-29
Profit/Loss
Retained earnings (accumulated losses)
-71,639 GBP2024-03-01 ~ 2025-02-28
Dividends Paid
-8,300 GBP2024-03-01 ~ 2025-02-28
Average Number of Employees
192024-03-01 ~ 2025-02-28
102023-02-01 ~ 2024-02-29
Intangible Assets - Gross Cost
Goodwill
209,000 GBP2025-02-28
209,000 GBP2024-02-29
Intangible Assets - Accumulated Amortisation & Impairment
Goodwill
69,667 GBP2025-02-28
27,867 GBP2024-02-29
Intangible Assets - Increase From Amortisation Charge for Year
Goodwill
41,800 GBP2024-03-01 ~ 2025-02-28
Intangible Assets
Goodwill
139,333 GBP2025-02-28
181,133 GBP2024-02-29
Property, Plant & Equipment - Gross Cost
Plant and equipment
182,224 GBP2025-02-28
181,167 GBP2024-02-29
Property, Plant & Equipment - Gross Cost
261,974 GBP2025-02-28
181,167 GBP2024-02-29
Vehicles
79,750 GBP2025-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
55,822 GBP2025-02-28
24,156 GBP2024-02-29
Property, Plant & Equipment - Accumulated Depreciation & Impairment
50,838 GBP2025-02-28
24,156 GBP2024-02-29
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
31,666 GBP2024-03-01 ~ 2025-02-28
Vehicles
-4,984 GBP2024-03-01 ~ 2025-02-28
Property, Plant & Equipment - Increase From Depreciation Charge for Year
26,682 GBP2024-03-01 ~ 2025-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Vehicles
-4,984 GBP2025-02-28
Property, Plant & Equipment
Plant and equipment
126,402 GBP2025-02-28
157,011 GBP2024-02-29
Vehicles
84,734 GBP2025-02-28
Trade Debtors/Trade Receivables
101,078 GBP2025-02-28
268,098 GBP2024-02-29
Other Debtors
95,446 GBP2025-02-28
16,556 GBP2024-02-29
Bank Overdrafts
Amounts falling due within one year
53,694 GBP2025-02-28
53,694 GBP2024-02-29
Finance Lease Liabilities - Total Present Value
Amounts falling due within one year
18,346 GBP2025-02-28
Trade Creditors/Trade Payables
Amounts falling due within one year
194,439 GBP2025-02-28
148,721 GBP2024-02-29
Taxation/Social Security Payable
Amounts falling due within one year
42,694 GBP2025-02-28
102 GBP2024-02-29
Other Creditors
Amounts falling due within one year
799 GBP2025-02-28
94,341 GBP2024-02-29
Bank Borrowings
Amounts falling due after one year
272,560 GBP2025-02-28
281,608 GBP2024-02-29
Finance Lease Liabilities - Total Present Value
Amounts falling due after one year
57,637 GBP2025-02-28

  • LAYANSON PHARMA LTD
    Info
    Registered number 14632770
    3 Bramley Road, Thornbury BS35 1EY
    PRIVATE LIMITED COMPANY incorporated on 2023-02-01 (3 years 7 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-12-30
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 14 July 2026 and licensed under the Open Government Licence v3.0.